What's your point? There's will always be competitor due to the potential market. Do you even know the revenue for Cholangiocarcinoma in the US even with CF33 capturing just 10% of that market???? BP will be interested in CF33 and Azer-Cel due to expansion into other solid and liquid cancer market.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $85.87M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.1¢ | $194.8K | 16.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 3329061 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 6413888 | 25 |
View Market Depth
| Last trade - 10.53am 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |